Eagle Pharmacy, Inc.

Form 483 issued February 27, 2025 · Hoover, Alabama

Inspection
Feb 18 – Feb 27, 2025
Investigator
Camerson E. Moore
Observations
5
Pages
4
FEI number
3011688532

In short: On February 27, 2025, FDA issued a Form 483 with 5 observations to Eagle Pharmacy, Inc. in Hoover, Alabama (FEI 3011688532) after an inspection that ran Feb 18 – Feb 27, 2025. The investigator was Camerson E. Moore. Most observations concern production and facilities & equipment.

At a glance

Production and facilities & equipment account for 4 of 5 observations.

Production2
Facilities & equipment2
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be…

  2. 02

    Protective apparel is not worn as necessary to protect…

  3. 03

    Equipment and utensils are not sanitized at appropriate intervals to prevent contamination that would alter the…

  4. 04

    Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Eagle Pharmacy, Inc.?

FDA listed 5 observations on this Form 483, mostly about production and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Eagle Pharmacy, Inc.?

Camerson E. Moore is named on this Form 483, for the inspection of Feb 18 – Feb 27, 2025. Each investigator has a profile showing what they cite most.

When was Eagle Pharmacy, Inc. inspected by FDA?

The inspection ran Feb 18 – Feb 27, 2025, and the Form 483 is dated February 27, 2025.

How do I get the full Form 483 for Eagle Pharmacy, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free